familymednews.com
Neuropsychiatric lupus (NPSLE), which is often referred to as central nervous system (CNS) lupus, can cause lupus patients to be afflicted with a variety of neuropsychiatric issues ranging from headaches and depression to seizures and a number of demyelinating conditions. Image Credit: vitstudio / Shutterstock.com Overview of lupus Systemic lupus erythematosus (SLE), which is formally referred to as lupus, is […]
Continue reading »
(HealthDay)—The intravenous drug Benlysta (belimumab) has been approved by the U.S. Food and Drug Administration to treat children with lupus, a chronic disease that triggers inflammation and damages tissues and organs throughout the body. Approved for adults since 2011, Benlysta is the first lupus treatment in the United States approved for children, the agency said in a news release. “While […]
Continue reading »
People with autoimmune diseases such as psoriasis, lupus and rheumatoid arthritis are at high risk of developing cardiovascular disease, even though none of these conditions seem to target the cardiovascular system directly. Now, researchers at Washington University School of Medicine in St. Louis believe they have begun to understand the link between the two. Researchers studying mice with a psoriasis-like […]
Continue reading »
New research indicates that belimumab, a monoclonal antibody therapy that targets a component of the immune system, provides considerable benefits to patients with systemic lupus erythematosus (SLE), a predominately female, chronic inflammatory disease that can affect virtually any organ. The Arthritis & Rheumatology findings are encouraging because lupus is among the leading causes of death in young women. SLE is […]
Continue reading »